3189 results for «686»
3189 results
Opening ceremony
08 Apr 2017 – From PCR Tokyo Valves 2017
Closing Ceremony and Awards
09 Apr 2017 – From PCR Tokyo Valves 2017
AsiaPCR/SingLIVE 2018: Closing Ceremony and Awards
27 Jan 2018 – From AsiaPCR/SingLIVE 2018
Join U. Kaul, T.H. Koh and S.T. Lim for the AsiaPCR/SingLIVE 2018 Closing Ceremony if you want to find out who this year's Best Abstract and Best Clinical case award winners are?
EuroPCR 2018 Opening Ceremony and Ethica Awards
22 May 2018 – From EuroPCR 2018
Join J. Fajadet and W. Wijns for the EuroPCR 2018 Opening Ceremony and find out who this year's Ethica Awards winners are!
Opening Ceremony: PCR London Valves 2018
10 Sep 2018 – From PCR London Valves 2018
Join J. J. Bax, B. Prendergast and J. Fajadet for the opening ceremony of PCR London Valves 2018 and find out more about the global challenge of the increasing burden of heart disease and the new technologies for the treatment of SHD.
Closing Ceremony and Highlights of the Course: PCR London Valves 2018
11 Sep 2018 – From PCR London Valves 2018
Join B. Prendergast for the closing ceremony of PCR London Valves 2018 and discover the course highlights!
A randomised trial comparing imaging-guided PCI with Orsiro vs Xience
18 May 2021
Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...
Authors :
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...
Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...
Author
